ARCA BIOPHARMA INC - COM (ABIO)

CUSIP: 00211Y506

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / COM
Total 13F shares
876,401
Share change
+55,410
Total reported value
$3,197,000
Put/Call ratio
62%
Price per share
$3.65
Number of holders
14
Value change
+$109,482
Number of buys
10
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 00211Y506?
CUSIP 00211Y506 identifies ABIO - ARCA BIOPHARMA INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ARCA BIOPHARMA INC - COM (ABIO) as of Q1 2021

As of 31 Mar 2021, ARCA BIOPHARMA INC - COM (ABIO) was held by 14 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 876,401 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GSA CAPITAL PARTNERS LLP, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, Tekla Capital Management LLC, CITADEL ADVISORS LLC, NORTHERN TRUST CORP, and PDT Partners, LLC. This page lists 14 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.